Zdrowie i gospodarka · 27/05/2020

FDA to Host Virtual Public Meeting on Prescription Drug User Fee Act and Biosimilar User Fee Act Amendments

The Food and Drug Administration (FDA) is hosting a virtual public meeting to discuss the Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments, and is seeking public comments. The meeting will be held via webcast due to unforeseen circumstances.